1. Regulatory Affairs, Simulations Plus Inc., 42505 10th Street West, Lancaster, California 93534-7059, United States
2. Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium
3. ANVISA, SIA Trecho 5́, Guara, Brasília, Federal District 71205-050, Brazil
4. Drug Product Technologies, Amgen Inc., Thousand Oaks, California 91320-1799, United States
5. Analytical Commercialization Technology, Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, New Jersey 07065, United States
6. Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States
7. Takeda Development Center Americas Inc., 300 Shire Way, Lexington, Massachusetts 02421, United States
8. College of Pharmacy, University of Florida, 6550 Sanger Rd., Orlando, Florida 32827, United States
9. Bayer HealthCare SAS, 59000 Lille, France, on behalf of Bayer AG, Pharmacometrics/Modeling and Simulation, Systems Pharmacology & Medicine, PBPK, Leverkusen, Germany
10. Office of Translational Science, Office of Clinical Pharmacology (OCP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States
11. Fraunhofer Institute of Translational Medicine and Pharmacology, Frankfurt am Main 60596, Germany
12. University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom
13. Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, New Jersey 07065, United States
14. Norwegian Medical Products Agency, Oslo 0213, Norway
15. Office of New Drug V, Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo 100-0013, Japan
16. European Medicines Agency (EMA), Domenico Scarlattilaan 6, Amsterdam 1083 HS, The Netherlands
17. Translational Drug Discovery and Development, Department of Pharmaceutical Bioscience, Uppsala University, Uppsala 751 05, Sweden
18. Swedish Medical Products Agency, Uppsala 752 37, Sweden
19. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmontonton T6G 2E1, Canada
20. Medicines & Healthcare Products Regulatory Agency, 10 S Colonnade, London SW1W 9SZ, United Kingdom
21. Global Biopharmaceutics, Drug Product Design, Pfizer, Sandwich CT13 9NJ, United Kingdom
22. Clinical Pharmacology, Kura Oncology Inc., Boston, Massachusetts 02210, United States
23. Global Research and Development, Small Molecules, Lonza, 63045 NE Corporate Pl., Bend, Oregon 97701, United States
24. Belgian Federal Agency for Medicines and Health Products, Galileelaan 5/03, Brussel 1210, Belgium
25. School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, United States
26. PK Sciences/Translational Medicine, BioMedical Research, Novartis, One Health Plaza, East Hanover, New Jersey 07936, United States
27. Regulatory CMC, AstraZeneca, 1 Medimmune Way, Gaithersburg, Maryland 20878, United States
28. Pharmaceutical Development, Bristol Myers Squibb, Route 206 & Province Line Road, Princeton, New Jersey 08543, United States
29. Pharmaceutical R&D, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland
30. Biopharmaceutics Science, New Modalities & Parenteral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg 431 50, Sweden
31. Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20903-1058, United States
32. Pharmaceutical Drugs Directorate (PDD), Health Canada, 1600 Scott St., Ottawa K1A 0K9, Canada
33. Global Drug Product Development, Global CMC Development, the Healthcare Business of Merck KGaA, Darmstadt D-64293, Germany